NCT05905445

Brief Summary

Periodontitis is an inflammatory disease that destroys tooth-supporting structures through oral bacterial plaque. ozone gel's act as an antimicrobial effect as an adjunct to conventional periodontal therapy (scaling and root planning). exposure of bacteria to ozone leads to the oxidation of the phospholipids and lipoproteins that comprise the bacterial cell membrane. Ozone gel has the potential to play an anti-inflammatory role in the treatment of periodontitis by monitoring both clinical and biological parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Mar 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

6 months

First QC Date

May 26, 2023

Last Update Submit

June 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • probing pocket depth

    change of probing pocket depth by ozone gel as an adjunct to non-surgical treatment

    baseline to one and three months

Secondary Outcomes (4)

  • plaque index

    baseline to one and three months

  • bleeding on probing

    baseline to one and three months

  • clinical attachment loss

    baseline to one and three months

  • level of platelet-activating factor in gingival crevicular fluid

    baseline to one and three months

Study Arms (2)

ozone gel with conventional scaling and root planning

EXPERIMENTAL

administered ozone gel in the probing pocket depth after scaling and root planning by a disposable plastic syringe with a blunt tip until the access ozone became out of the pocket. this procedure is made at baseline and in the first month. instructed the patient not to eat or drink for at least 30 minutes

Drug: ozone gel

only conventional scaling and root planning

NO INTERVENTION

only scaling and root planning without any intervention.

Interventions

the activity of omega-3 in the ozone gel may be advantageous as a host-modulating agent in the supplemental treatment of periodontitis

ozone gel with conventional scaling and root planning

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The patient should be systemically healthy
  • The patient has periodontitis equal to or more than two non-adjacent teeth, with probing pocket depth equal to or more than 4mm.
  • Patients capable of following orders and motivation

You may not qualify if:

  • Patients with removable dentures who undergo orthodontic therapy.
  • Patients with teeth suffer from endo-periodontal lesions.
  • Patients have three months of using anti-inflammatory medications, antibiotics, immune suppressants, or oral contraceptives.
  • Patients having systemic conditions that affect the condition.
  • Pregnant or nursing mothers.
  • Patients who are smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghufran Falih Hassen

Baghdad, Iraq

Location

Related Publications (1)

  • Colombo M, Gallo S, Garofoli A, Poggio C, Arciola CR, Scribante A. Ozone Gel in Chronic Periodontal Disease: A Randomized Clinical Trial on the Anti-Inflammatory Effects of Ozone Application. Biology (Basel). 2021 Jul 6;10(7):625. doi: 10.3390/biology10070625.

    PMID: 34356480BACKGROUND

MeSH Terms

Conditions

Periodontal PocketPeriodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
postgraduate student

Study Record Dates

First Submitted

May 26, 2023

First Posted

June 15, 2023

Study Start

March 9, 2022

Primary Completion

September 9, 2022

Study Completion

September 9, 2022

Last Updated

June 15, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations